{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:39:30Z","timestamp":1792823970203,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["71003Y3035"],"award-info":[{"award-number":["71003Y3035"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2510500"],"award-info":[{"award-number":["2024YFC2510500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1103300"],"award-info":[{"award-number":["2022YFA1103300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218854","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:38:45Z","timestamp":1790177925000},"page":"218854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hematopoietic stem cell transplantation for acquired aplastic anemia in 2024: Report from the Chinese Blood and Marrow Transplantation Registry Group (CBMTRG)"],"prefix":"10.1016","volume":"661","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0267-1081","authenticated-orcid":false,"given":"Lanping","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilei","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9418-4901","authenticated-orcid":false,"given":"Shunqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5912-2633","authenticated-orcid":false,"given":"Baodong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3334-9113","authenticated-orcid":false,"given":"Daihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.canlet.2026.218854_bib1","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218854_bib2","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2025019051","article-title":"American society of hematology 2026 guidelines for the diagnosis and management of severe acquired aplastic anemia","author":"Scheinberg","year":"2026","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218854_bib3","article-title":"Chinese society of hematology clinical practice guidelines for the comprehensive management of allogeneic hematopoietic stem cell transplantation in patients with severe aplastic anemia","author":"Xu","year":"2025","journal-title":"Chin. Med. J."},{"issue":"12","key":"10.1016\/j.canlet.2026.218854_bib4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jtct.2024.09.017","article-title":"Allogeneic hematopoietic cell transplantation for the treatment of severe Aplastic Anemia: Evidence-based guidelines from the American society for transplantation and cellular therapy","volume":"30","author":"Iftikhar","year":"2024","journal-title":"Transplant. Cell. Ther."},{"issue":"3","key":"10.1016\/j.canlet.2026.218854_bib5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British society for haematology guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218854_bib6","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/ajh.70319","article-title":"Allogeneic HSCT in aplastic anemia: current evidence, controversies, and practical decision-making","volume":"101","author":"Law","year":"2026","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218854_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-022-01324-1","article-title":"Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218854_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3324\/haematol.10075","article-title":"Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the european Group for blood and marrow transplantation (EBMT)","volume":"92","author":"Locasciulli","year":"2007","journal-title":"Haematologica"},{"issue":"25","key":"10.1016\/j.canlet.2026.218854_bib9","first-page":"3031","article-title":"Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia","volume":"141","author":"DeZern","year":"2023","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.canlet.2026.218854_bib10","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1016\/S2352-3026(22)00206-X","article-title":"Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial","volume":"9","author":"DeZern","year":"2022","journal-title":"Lancet Haematol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218854_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.scib.2022.01.024","article-title":"Long-term follow-up of haploidentical transplantation in relapsed\/refractory severe aplastic anemia: a multicenter prospective study","volume":"67","author":"Xu","year":"2022","journal-title":"Sci. Bullet."},{"issue":"12","key":"10.1016\/j.canlet.2026.218854_bib12","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3324\/haematol.2022.280758","article-title":"Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study","volume":"107","author":"Xu","year":"2022","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.canlet.2026.218854_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.13614","volume":"171","author":"Dufour","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218854_bib14","doi-asserted-by":"crossref","first-page":"980.e981","DOI":"10.1016\/j.jtct.2026.04.018","article-title":"Are HLA-haploidentical relatives a donor choice for patients with severe aplastic anemia? A GATMO-TC experience","volume":"32","author":"Basquiera","year":"2026","journal-title":"Transplant. Cell. Ther."},{"issue":"8","key":"10.1016\/j.canlet.2026.218854_bib15","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/bloodadvances.2025018548","article-title":"Allogeneic hematopoietic cell transplantation for aplastic anemia: a single institution experience across 6 decades","volume":"10","author":"Olivieri","year":"2026","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.canlet.2026.218854_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jtct.2025.05.014","article-title":"Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy - a report from the CIBMTR","volume":"31","author":"Spellman","year":"2025","journal-title":"Transplant. Cell. Ther."},{"issue":"12","key":"10.1016\/j.canlet.2026.218854_bib17","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41409-024-02419-8","article-title":"Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese blood and marrow transplantation registry group","volume":"59","author":"Xu","year":"2024","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.canlet.2026.218854_bib18","doi-asserted-by":"crossref","first-page":"808.e801","DOI":"10.1016\/j.jtct.2025.06.014","article-title":"Comparative study of Bu\/Cy\/ATG and Flu\/Cy\/ATG conditioning regimens for unrelated donor hematopoietic stem cell transplantation in severe aplastic anemia","volume":"31","author":"Wu","year":"2025","journal-title":"Transplant. Cell. Ther."},{"issue":"7","key":"10.1016\/j.canlet.2026.218854_bib19","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s41409-022-01682-x","article-title":"Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia","volume":"57","author":"Xu","year":"2022","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.canlet.2026.218854_bib20","doi-asserted-by":"crossref","first-page":"663.e661","DOI":"10.1016\/j.jtct.2025.10.013","article-title":"Survival advantage of reduced-toxicity conditioning in haploidentical hematopoietic cell transplantation for severe aplastic anemia patients with pre-transplant comorbidities","volume":"32","author":"Lin","year":"2026","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.canlet.2026.218854_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720965411","article-title":"Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia","volume":"11","author":"Liu","year":"2020","journal-title":"Therapeut. Adv. Hematol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218854_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-026-00753-9","article-title":"Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in patients with aplastic anemia undergoing PBSC-only allogeneic stem cell transplantation: a prospective phase II study","volume":"15","author":"Zhang","year":"2026","journal-title":"Exp. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218854_bib23","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.scib.2026.01.057","article-title":"Who is the best allogeneic hematopoietic stem cell transplant donor for severe aplastic anemia? Data from the chinese bone marrow Transplantation Registry group (CBMTRG)","volume":"71","author":"Xu","year":"2026","journal-title":"Sci. Bullet."},{"issue":"1","key":"10.1016\/j.canlet.2026.218854_bib24","doi-asserted-by":"crossref","first-page":"48.e41","DOI":"10.1016\/j.jtct.2022.10.006","article-title":"Alternative transplantation with post-transplantation cyclophosphamide in aplastic anemia: a retrospective report from the BMF-WG of Hunan Province, China","volume":"29","author":"Gong","year":"2023","journal-title":"Transplant. Cell. Ther."},{"issue":"7","key":"10.1016\/j.canlet.2026.218854_bib25","doi-asserted-by":"crossref","first-page":"396.e391","DOI":"10.1016\/j.jtct.2022.04.021","article-title":"Comparisons of modified post-transplantation cyclophosphamide and granulocyte colony-stimulating factor\/Antithymocyte globulin regimens for haploidentical stem cell transplantation in patients with aplastic anemia","volume":"28","author":"Li","year":"2022","journal-title":"Transplant. Cell. Ther."},{"issue":"12","key":"10.1016\/j.canlet.2026.218854_bib26","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3324\/haematol.2010.026682","article-title":"Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-Matched sibling donors","volume":"95","author":"Gupta","year":"2010","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.canlet.2026.218854_bib27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bbmt.2018.08.029","article-title":"Allogeneic hematopoietic cell transplantation in patients aged 50Years or older with severe aplastic anemia","volume":"25","author":"Rice","year":"2019","journal-title":"Biol. Blood Marrow Transplant. : J. Am. Soc. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.canlet.2026.218854_bib28","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3324\/haematol.2023.284581","article-title":"The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese blood and marrow transplant registry group","volume":"109","author":"Xu","year":"2024","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.canlet.2026.218854_bib29","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1182\/bloodadvances.2019000480","article-title":"Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years","volume":"3","author":"Sheth","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218854_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-025-02524-2","article-title":"The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT","author":"Passweg","year":"2025","journal-title":"Bone Marrow Transplant."},{"issue":"20","key":"10.1016\/j.canlet.2026.218854_bib31","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/bloodadvances.2019000722","article-title":"Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia","volume":"3","author":"Bejanyan","year":"2019","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.canlet.2026.218854_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.2024024173","article-title":"Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT","volume":"144","author":"Montoro","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218854_bib33","article-title":"Long-term follow-up of the Baltimore experience with hematopoietic cell transplantation for severe aplastic anemia using post-transplant cyclophosphamide","author":"DeZern","year":"2025","journal-title":"Transplant. Cell. Ther."},{"issue":"8","key":"10.1016\/j.canlet.2026.218854_bib34","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41409-025-02633-y","article-title":"Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT","volume":"60","author":"Montoro","year":"2025","journal-title":"Bone Marrow Transplant."},{"issue":"17","key":"10.1016\/j.canlet.2026.218854_bib35","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2017-09-807859","article-title":"Transplant outcome for patients with acquired aplastic anemia over the age of 40: has the outcome improved?","volume":"131","author":"Giammarco","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.canlet.2026.218854_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13810","article-title":"Comparable survival outcome between transplantation from haploidentical donor and matched related donor or unrelated donor for severe aplastic anemia patients aged 40 years and older: a retrospective multicenter cohort study","volume":"34","author":"Zhang","year":"2020","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.canlet.2026.218854_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217594","article-title":"Comparable survival outcomes in HLA-matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40-50: a CBMTR registry-based propensity score matching analysis over the last decade","volume":"621","author":"Xu","year":"2025","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.canlet.2026.218854_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70359","volume":"39","author":"Zhao","year":"2025","journal-title":"Clin. Transplant."},{"issue":"9","key":"10.1016\/j.canlet.2026.218854_bib39","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s41409-025-02617-y","article-title":"Clinical outcomes of offspring and matched unrelated donor transplants in relapsed or refractory severe aplastic anemia patients aged 40-50: a retrospective analysis from the CBMTR over the past decade","volume":"60","author":"Zhao","year":"2025","journal-title":"Bone Marrow Transplant."},{"issue":"20","key":"10.1016\/j.canlet.2026.218854_bib40","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1182\/bloodadvances.2024013853","article-title":"Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations","volume":"8","author":"Mehta","year":"2024","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.canlet.2026.218854_bib41","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/TP.0000000000003342","article-title":"Comparable outcomes between unrelated and haploidentical stem cell transplantation in adult patients with severe aplastic anemia","volume":"105","author":"Park","year":"2021","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.canlet.2026.218854_bib42","doi-asserted-by":"crossref","first-page":"82.e81","DOI":"10.1016\/j.bbmt.2020.10.001","volume":"27","author":"Takenaka","year":"2021","journal-title":"Transplant. Cell. Ther."},{"issue":"12","key":"10.1016\/j.canlet.2026.218854_bib43","doi-asserted-by":"crossref","first-page":"956.e951","DOI":"10.1016\/j.jtct.2025.08.028","article-title":"The optimal adjuvant reinfusion strategy for aplastic anemia: umbilical cord blood or mesenchymal stem cells? A single-center retrospective study","volume":"31","author":"Tan","year":"2025","journal-title":"Transplant. Cell. Ther."},{"issue":"11","key":"10.1016\/j.canlet.2026.218854_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.08.016","article-title":"Efficacy of a modified post-transplant cyclophosphamide regimen for unrelated donor hematopoietic stem cell transplantation in patients with severe aplastic anemia: a prospective study","volume":"30","author":"Chen","year":"2024","journal-title":"Transplant. Cell. Ther."},{"issue":"6","key":"10.1016\/j.canlet.2026.218854_bib45","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s11427-019-9585-x","article-title":"Haploidentical hematopoietic cell transplantation for severe acquired aplastic anemia: a case-control study of post-transplant cyclophosphamide included regimen vs. anti-thymocyte globulin & colony-stimulating factor-based regimen","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"3","key":"10.1016\/j.canlet.2026.218854_bib46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbmt.2019.10.004","article-title":"Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia","volume":"26","author":"Kako","year":"2020","journal-title":"Biol. Blood Marrow Transplant. : J. Am. Soc. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.canlet.2026.218854_bib47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V67.3.811.811","article-title":"Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease","volume":"67","author":"Hill","year":"1986","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.canlet.2026.218854_bib48","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","article-title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600618X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600618X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:20:21Z","timestamp":1792822821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352600618X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":48,"alternative-id":["S030438352600618X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218854","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic stem cell transplantation for acquired aplastic anemia in 2024: Report from the Chinese Blood and Marrow Transplantation Registry Group (CBMTRG)","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218854"}}